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Abstract
Streptococcus pyogenes (group A streptococcus, GAS) is a major cause of necrotizing soft tissue infection (NSTI). On rare occasions, other
b-haemolytic streptococci may also cause NSTI, but the signiﬁcance and nature of these infections has not been thoroughly investigated. In
this study, clinical and molecular characteristics of NSTI caused by GAS and b-haemolytic Streptococcus dysgalactiae subsp. equisimilis of
groups C and G (GCS/GGS) in western Norway during 2000–09 are presented. Clinical data were included retrospectively. The bacterial
isolates were subsequently emm typed and screened for the presence of genes encoding streptococcal superantigens. Seventy cases were
identiﬁed, corresponding to a mean annual incidence rate of 1.4 per 100 000. Sixty-one of the cases were associated with GAS, whereas
GCS/GGS accounted for the remaining nine cases. The in-hospital case fatality rates of GAS and GCS/GGS disease were 11% and 33%,
respectively. The GCS/GGS patients were older, had comorbidities more often and had anatomically more superﬁcial disease than the GAS
patients. High age and toxic shock syndrome were associated with mortality. The Laboratory Risk Indicator for Necrotizing Fasciitis
laboratory score showed high values (≥6) in only 31 of 67 cases. Among the available 42 GAS isolates, the most predominant emm types
were emm1, emm3 and emm4. The virulence gene proﬁles were strongly correlated to emm type. The number of superantigen genes was
low in the four available GCS/GGS isolates. Our ﬁndings indicate a high frequency of streptococcal necrotizing fasciitis in our community.
GCS/GGS infections contribute to the disease burden, but differ from GAS cases in frequency and predisposing factors.
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Abstract
Assessment of antibody responses to pneumococcal colonization in early childhood may aid our understanding of protection and inform
vaccine antigen selection. Serum samples were collected from mother-infant pairs during a longitudinal pneumococcal colonization study in
Burmese refugees. Maternal and cord sera were collected at birth and infants were bled monthly (1–24 months of age). Nasopharyngeal
swabs were taken monthly to detect colonization. Serum IgG titres to 27 pneumococcal protein antigens were measured in 2624 sera and
IgG to dominant serotypes (6B, 14, 19F, 19A and 23F) were quantiﬁed in 864 infant sera. Antibodies to all protein antigens were detectable
in maternal sera. Titres to four proteins (LytB, PcpA, PhtD and PhtE) were signiﬁcantly higher in mothers colonized by pneumococci at
delivery. Maternally-derived antibodies to PiuA and Spr0096 were associated with delayed pneumococcal acquisition in infants in univariate,
but not multivariate models. Controlling for infant age and previous homologous serotype exposure, nasopharyngeal acquisition of
serotypes 19A, 23F, 14 or 19F was associated signiﬁcantly with a ≥2-fold antibody response to the homologous capsule (OR 12.84, 7.52,
6.52, 5.33; p <0.05). Acquisition of pneumococcal serotypes in the nasopharynx of infants was not signiﬁcantly associated with a ≥2-fold rise
in antibodies to any of the protein antigens studied. In conclusion, nasopharyngeal colonization in young children resulted in demonstrable
serum IgG responses to pneumococcal capsules and surface/virulence proteins. However, the relationship between serum IgG and the
prevention of, or response to, pneumococcal nasopharyngeal colonization remains complex. Mechanisms other than serum IgG are likely to
have a role but are currently poorly understood.
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Abstract
The role of oral bacteria in the development of chemotherapy-related oral mucositis has not been fully elucidated. This study aimed to
investigate oral bacterial community diversity and dynamics in paediatric patients with malignancies in relation to the occurrence of oral
mucositis. Patients with malignancies (n = 37) and reference individuals without known systemic disorders (n = 38) were recruited. For
patients, oral bacterial samples were taken from mucosal surfaces both at the time of malignancy diagnosis and during chemotherapy. If oral
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mucositis occurred, samples were taken from the surface of the mucositis lesions. Oral mucosal bacterial samples were also taken from
reference individuals. All samples were assessed using a 16S ribosomal RNA gene 454 pyrosequencing method. A lower microbial diversity
(p < 0.01) and a higher intersubject variability (p < 0.001) were found in patients as compared with reference individuals. At the time of
malignancy diagnosis (i.e. before chemotherapy) patients that later developed mucositis showed a higher microbial diversity (p < 0.05) and a
higher intersubject variability (p < 0.001) compared with those without mucositis. The change of bacterial composition during
chemotherapy was more pronounced in patients who later developed mucositis than those without mucositis (p < 0.01). In conclusion, we
found a higher microbial diversity at the time of malignancy diagnosis in patients who later develop oral mucositis and that these patients had
a more signiﬁcant modiﬁcation of the bacterial community by chemotherapy before the occurrence of mucositis. These ﬁndings may
possibly be of clinical importance in developing better strategies for personalized preventive management.
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